Vacina quadrivalente contra HPV 6, 11, 16, 18
Atualmente as manifestações clínicas causadas pelo HPV(Papilomavírus humano), tais como câncer de colo de útero, vagi-na, vulva, ânus, laringe, orofaringe e verrugas genitais podem serconsiderados doenças imunopreveníveis.
Nelson Vespa Junior
doaj
Prevalence of Human Papillomavirus Infection and Cervical Cancer Screening among Riverside Women of the Brazilian Amazon. [PDF]
Duarte DV +8 more
europepmc +1 more source
HPV immunization in Brazil and proposals to increase adherence to vaccination campaigns. [PDF]
Santos WM, Santos DM, Fernandes MS.
europepmc +1 more source
Importance of vaccination against human papillomavirus in a rural settlement in Terenos, Mato Grosso do Sul. [PDF]
Souza ZA +7 more
europepmc +1 more source
Nova vacina contra o papilomavírus humano
Nelson Calado
doaj +1 more source
Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening. [PDF]
McGill F +8 more
europepmc +1 more source
Detection of High-Risk Human Papillomavirus in Cervix Sample in an 11.3-year Follow-Up after Vaccination against HPV 16/18. [PDF]
Teixeira CSC +4 more
europepmc +1 more source
Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region. [PDF]
Martins LFL +8 more
europepmc +1 more source
Systematic literature review of primary and secondary cervical cancer prevention programs in South America. [PDF]
Gomes MLS +7 more
europepmc +1 more source
A vacina contra o papilomavírus humano
José Eluf Neto
doaj +1 more source

